Vericel (VCEL) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Vericel Revenue Highlights

Latest Revenue (Y)

$197.52M

Latest Revenue (Q)

$52.66M

Main Segment (Y)

MACI Implants And Kits

Vericel Revenue by Period

Vericel Revenue by Year

Date	Revenue	Change
2023-12-31	$197.52M	20.17%
2022-12-31	$164.37M	5.24%
2021-12-31	$156.18M	25.77%
2020-12-31	$124.18M	5.37%
2019-12-31	$117.85M	29.71%
2018-12-31	$90.86M	42.13%
2017-12-31	$63.92M	17.54%
2016-12-31	$54.38M	6.28%
2015-12-31	$51.17M	77.69%
2014-12-31	$28.80M	151457.89%
2013-12-31	$19.00K	-9.52%
2012-12-31	$21.00K	16.67%
2011-12-31	$18.00K	-79.78%
2010-06-30	$89.00K	-51.10%
2009-06-30	$182.00K	-65.13%
2008-06-30	$522.00K	-23.80%
2007-06-30	$685.00K	-20.63%
2006-06-30	$863.00K	-5.06%
2005-06-30	$909.00K	-30.18%
2004-06-30	$1.30M	54.27%
2003-06-30	$844.00K	-3.76%
2002-06-30	$877.00K	-2.45%
2001-06-30	$899.00K	-21.83%
2000-06-30	$1.15M	30.53%
1999-06-30	$881.00K	253.82%
1998-06-30	$249.00K	-37.75%
1997-06-30	$400.00K	-75.00%
1996-06-30	$1.60M	-

Vericel generated $197.52M in revenue during NA 2023, up 20.17% compared to the previous quarter, and up 217.39% compared to the same period a year ago.

Vericel Revenue by Quarter

Date	Revenue	Change
2024-06-30	$52.66M	2.69%
2024-03-31	$51.28M	-21.10%
2023-12-31	$65.00M	42.59%
2023-09-30	$45.58M	-0.74%
2023-06-30	$45.92M	11.96%
2023-03-31	$41.02M	-22.16%
2022-12-31	$52.69M	36.69%
2022-09-30	$38.55M	4.06%
2022-06-30	$37.05M	2.69%
2022-03-31	$36.07M	-24.20%
2021-12-31	$47.59M	37.92%
2021-09-30	$34.51M	-12.69%
2021-06-30	$39.52M	14.32%
2021-03-31	$34.57M	-23.57%
2020-12-31	$45.23M	40.21%
2020-09-30	$32.26M	61.18%
2020-06-30	$20.01M	-24.98%
2020-03-31	$26.68M	-32.27%
2019-12-31	$39.39M	29.15%
2019-09-30	$30.50M	16.63%
2019-06-30	$26.15M	19.90%
2019-03-31	$21.81M	-30.40%
2018-12-31	$31.34M	39.37%
2018-09-30	$22.48M	18.27%
2018-06-30	$19.01M	5.46%
2018-03-31	$18.03M	-22.80%
2017-12-31	$23.35M	63.74%
2017-09-30	$14.26M	-15.89%
2017-06-30	$16.95M	81.10%
2017-03-31	$9.36M	-43.35%
2016-12-31	$16.52M	51.18%
2016-09-30	$10.93M	-14.77%
2016-06-30	$12.82M	-9.11%
2016-03-31	$14.11M	-8.51%
2015-12-31	$15.42M	36.35%
2015-09-30	$11.31M	-16.78%
2015-06-30	$13.59M	25.27%
2015-03-31	$10.85M	-26.23%
2014-12-31	$14.71M	52.27%
2014-09-30	$9.66M	117.92%
2014-06-30	$4.43M	100.00%
2014-03-31	-	-100.00%
2013-12-31	$8.00K	100.00%
2013-09-30	-	-100.00%
2013-06-30	$3.00K	-62.50%
2013-03-31	$8.00K	-57.89%
2012-12-31	$19.00K	100.00%
2012-09-30	-	100.00%
2012-06-30	-	-100.00%
2012-03-31	$2.00K	100.00%
2011-12-31	-	-100.00%
2011-09-30	$9.00K	100.00%
2011-06-30	-	-100.00%
2011-03-31	$9.00K	100.00%
2010-09-30	-	100.00%
2010-06-30	-	100.00%
2010-03-31	-	-100.00%
2009-12-31	$16.00K	-78.08%
2009-09-30	$73.00K	5.80%
2009-06-30	$69.00K	18.97%
2009-03-31	$58.00K	107.14%
2008-12-31	$28.00K	3.70%
2008-09-30	$27.00K	-81.88%
2008-06-30	$149.00K	-26.24%
2008-03-31	$202.00K	-

Vericel generated $52.66M in revenue during Q2 2024, up 2.69% compared to the previous quarter, and up 128.39% compared to the same period a year ago.

Vericel Revenue Breakdown

Vericel Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20
MACI Implants And Kits	$164.80M	$131.97M	$111.55M	-
NexoBrid	-	-	-	$2.20M

Vericel's latest annual revenue breakdown by segment (product or service), as of Dec 23: MACI Implants And Kits (100.00%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 24	Mar 24	Dec 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Sep 21	Jun 21	Mar 21	Sep 20	Sep 19	Jun 19	Mar 19	Sep 18	Jun 18	Mar 18
MACI Implants And Kits	$44.66M	$44.13M	$40.18M	$94.27M	$36.34M	$34.19M	-	-	-	-	-	-	-	-	-	-	-	-	-
MACI Implants And Kits Member	-	-	-	-	-	-	$31.01M	$28.61M	$26.00M	-	-	-	-	-	-	-	-	-	-
MACI Implants and Kits, and Epicel	-	-	-	-	-	-	-	-	-	$33.72M	$38.68M	$33.63M	$31.02M	-	-	-	-	-	-
Product	-	-	-	-	-	-	-	-	-	-	-	-	-	$30.50M	$26.15M	$21.81M	$22.48M	$19.01M	-
Epicel	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$5.97M
Biopsy Kits	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$436.00K
Implants	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.01M

Vericel's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: MACI Implants And Kits (100.00%).

Vericel Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
BPMC	Blueprint Medicines	$249.38M	$128.18M
VCEL	Vericel	$197.52M	$52.66M
XNCR	Xencor	$168.34M	$16.96M
RGNX	REGENXBIO	$90.24M	$24.20M
MRUS	Merus	$43.95M	$11.77M
RLAY	Relay Therapeutics	$25.55M	-
IDYA	IDEAYA Biosciences	$23.39M	-
RVMD	Revolution Medicines	$11.58M	-
CLGN	CollPlant Bio	$10.96M	$98.00K
MREO	Mereo BioPharma Group	$10.00M	-
STOK	Stoke Therapeutics	$8.78M	$4.89M
CYTK	Cytokinetics	$7.53M	$463.00K
CRNX	Crinetics Pharmaceuticals	$4.01M	-
IPSC	Century Therapeutics	$2.23M	$791.00K
PLRX	Pliant Therapeutics	$1.58M	-
CMRX	Chimerix	$324.00K	$129.00K
KROS	Keros Therapeutics	$151.00K	$37.00K
XFOR	X4 Pharmaceuticals	-	$560.00K
DAWN	Day One Biopharmaceuticals	-	$20.07M
DYN	Dyne Therapeutics	-	-
SNDX	Syndax Pharmaceuticals	-	$12.50M
TERN	Terns Pharmaceuticals	-	-

VCEL Revenue FAQ

What is Vericel’s yearly revenue?

Vericel's yearly revenue for 2023 was $197.52M, representing an increase of 20.17% compared to 2022. The company's yearly revenue for 2022 was $164.36M, representing an increase of 5.24% compared to 2021. VCEL's yearly revenue for 2021 was $156.18M, representing an increase of 25.77% compared to 2020.

What is Vericel’s quarterly revenue?

Vericel's quarterly revenue for Q2 2024 was $52.66M, a 2.69% increase from the previous quarter (Q1 2024), and a 14.68% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $51.28M, a -21.10% decrease from the previous quarter (Q4 2023), and a 25.02% increase year-over-year (Q1 2023). VCEL's quarterly revenue for Q4 2023 was $65M, a 42.59% increase from the previous quarter (Q3 2023), and a 23.35% increase year-over-year (Q4 2022).

What is Vericel’s revenue growth rate?

Vericel's revenue growth rate for the last 3 years (2021-2023) was 26.46%, and for the last 5 years (2019-2023) was 67.60%.

What are Vericel’s revenue streams?

Vericel's revenue streams in c 23 are MACI Implants And Kits

What is Vericel’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Vericel was MACI Implants And Kits. This segment made a revenue of $164.8M, representing 100.00% of the company's total revenue.